［1］Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］. CA Cancer J Clin, 68: 394-424.
［2］Liu Y, Mou X, Zhou D, et al. Extraction of flavonoids from Chrysanthemum morifolium and antitumor activity in vitro［J］. Exp Thera Med, 2017, 15(2): 1203-1210.
［3］钟良瑞, 陈华, 景晶, 等. 三叶青黄酮抑制肺癌A549细胞生长与蛋白酶体活性的关系研究［J］. 中国临床药理学与治疗学, 2017, 22(10): 1123-1126.
［4］Liu H, Gao Y, Dong Y, et al. Flavonoids active against osteosarcoma: a review of the molecular mechanisms involved ［J］. Curr Pharma Des, 2017, 23(13): 1993-2001.
［5］Shirisha G, Mandava K, Batchu UR, et al. Antitumor and antioxidant effects of flavonoid fraction of citrus sinensis peel extract ［J］. Pharmaco J, 2019, 11(1): 57-63.
［6］Huynh DL, Sharma N, Singh AK, et al. Anti-tumor activity of wogonin, an extract from Scutellaria baicalensis, through regulating different signaling pathways ［J］. Chin J Nat Med, 2017, 15(1):15-40.
［7］Zhao YK,Zhang LL,Wu YF, et al. Selective anti-tumor activity of wogonin targeting the Warburg effect through stablizing p53［J］. Pharmacol Res, 2018, 135: 49-59.
［8］Wu X, Zhang H, Salmani JM, et al. Advances of wogonin, an extract from Scutellaria baicalensis, for the treatment of multiple tumors ［J］. Oncotar Thera, 2016, 9(1): 2935-2943.
［9］Li SJ, Sun SJ, Jie G, et al. Wogonin induces Beclin-1/PI3K and reactive oxygen species-mediated autophagy in human pancreatic cancer cells ［J］. Oncol Lett, 2016, 12(6): 5059-5067.
［10］杨莉, 尤启冬, 杨勇, 等. 汉黄芩素抗肿瘤作用的研究进展［J］. 中国药科大学学报, 2009, 40(6): 576-579.
［11］Fu R, Chen Y, Wang XP, et al. Wogonin inhibits multiple myeloma-stimulated angiogenesis via c-Myc/VHL/HIF-1α signaling axis ［J］. Oncotarget, 2016, 7(5): 5715-5727.
［12］Talbi A, Zhao D, Liu Q, et al. Pharmacokinetics, Tissue Distribution, Excretion and Plasma Protein Binding Studies of Wogonin in Rats［J］. Molecules, 2014, 19(5): 5538-5549.
［13］Li L, Lu N, Dai Q, et al. GL-V9, a newly synthetic flavonoid derivative, induces mitochondrial-mediated apoptosis and G2/M cell cycle arrest in human hepatocellular carcinoma HepG2 cells ［J］. Eur J Pharmacol, 2011, 670(1): 13-21.
［14］Zhao K, Li G, Yao Y, et al. Activation of phospholipase C-γ1 and translocation of phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase contribute to GL-V9-induced apoptosis in human gastric cancer cells［J］. Exp Cell Res, 2017, 356(1): 8-19.
［15］Zhao L, Li W, Zhou Y, et al. The overexpression and nuclear translocation of Trx-1 during hypoxia confers on HepG2 cells resistance to DDP, and GL-V9 reverses the resistance by suppressing the Trx-1/Ref-1 axis ［J］. Free Radic Biol Med, 2015, 82: 29-41.
［16］Xing H, Ren C, Kong Y, et al. Determination of GL‐V9, a derivative of wogonin, in rat plasma by UPLC‐MS/MS and its application to a pharmacokinetic study after oral and pulmonary administration ［J］. Biomed Chromatogr, 2019, doi: 10.1002/bmc.4556.
［17］Nakamura A, Nakajima M, Yamanaka H, et al. Expression of UGT1A and UGT2B mRNA in Human Normal Tissues and Various Cell Lines［J］. Drug Metab Dispos, 2008, 36(8): 1461-1464.
［18］Ohno S, Nakajin S. Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction ［J］. Drug Metab Dispos Biol Fate Chem, 2009, 37(1): 32.
［19］Chen S, Feng D. Noninvasive quantification of the differential portal and arterial contribution to the liver blood supply from PET measurements using the 11C-acetate kinetic model ［J］. IEEE Trans Biomed Eng, 2004, 51(9): 1579-1585.
［20］Xing H, Ren C, Kong Y, et al. Mechanistic study of absorption and first‐pass metabolism of GL‐V9, a derivative of wogonin［J］. Biopharma Drug Dispos, 2019, 40(3/4): 151-161.
［21］Xing, H, Kong, D, Ning, C, et al. An investigation on glucuronidation metabolite identification, isozyme contribution, and species differences of GL-V9 in vitro and in vivo ［J］. Molecules, 2019, 24(8): 1576.
［22］何佳珂, 于洋, 陈西敬, 等. 黄酮类化合物的药物代谢研究进展［J］. 中国中药杂志, 2010, 35(21): 7-12.
［23］Wong YC, Zhang L, Lin G, et al. Structure-activity relationships of the glucuronidation of flavonoids by human glucuronosyltransferases ［J］. Expert Opin Drug Metab Toxicol, 2009, 5(11): 1399-1419.